Back to News
Market Impact: 0.25

2 of the Safest Ultra-High-Yield Dividend Stocks to Buy Right Now

CVXKMBAVGOKVUENFLXNVDANDAQ
Energy Markets & PricesCommodities & Raw MaterialsCapital Returns (Dividends / Buybacks)Corporate Guidance & OutlookCompany FundamentalsM&A & RestructuringCorporate EarningsConsumer Demand & Retail
2 of the Safest Ultra-High-Yield Dividend Stocks to Buy Right Now

Chevron is presented as a conservative income play, yielding ~4% with 37 consecutive years of dividend increases and a 2030 plan to grow FCF and EPS by at least 10% at Brent $70, while achieving FCF breakeven at $50/bbl; the company can also rely on its balance sheet or spending cuts if prices fall. Kimberly-Clark, trading below $100 at a 12-year low, raised its quarterly dividend to $1.28 and yields ~5.2%; the company plans to acquire Kenvue (close targeted by end-2026), expects billions in annual cost synergies, generated $1.7 billion FCF in 2025 versus $1.66 billion in dividends paid, and trades at a ~13.1 forward P/E, positioning it as a value-oriented dividend stock.

Analysis

Market structure: Chevron (CVX) and Kimberly‑Clark (KMB) are beneficiaries of a two‑tier market where capital‑rich integrated majors and cash‑generating staples win defensive yield flows. CVX’s plan (FCF/eps +10% at Brent ~$70, FCF breakeven ~$50) strengthens its pricing power vs higher‑cost E&Ps (losers: OXY, smaller producers) and should compress credit spreads for energy names if Brent stays >$60 for multiple quarters. KMB’s acquisition of Kenvue increases scale in personal care but shifts competitive dynamics toward consolidation, pressuring midsized branded peers lacking scale or cost flexibility. Risk assessment: Tail risks include a deep oil collapse (Brent < $50 for >3 months) forcing capex cuts and dividend/ buyback pressure at smaller producers, and M&A/regulatory failure or a >25% synergy shortfall at KMB delaying accretion beyond 2028. Time horizons: immediate (days) — react to Brent moves and CPI prints; short (weeks–months) — Q1 results and any regulatory filings for Kenvue; long (years to 2030) — realization of CVX guidance and KMB integration. Hidden dependencies include commodity hedging profiles, pension/cash tax timing on Kenvue, and FX exposure on consumer brands. Trade implications: Favor quality long exposure to CVX and KMB but size with explicit commodity and deal risk hedges: CVX is a capital‑return play that outperforms if Brent stays >$65 for 6+ months; KMB is a value/corporate‑action trade if acquired assets deliver >$1.5–2.0bn synergies by year two post‑close. Options strategies: use LEAPs to buy optionality on both names while selling short‑dated calls to finance cost; use short beta exposure to high‑leverage E&Ps to express relative safety. Contrarian angles: Consensus underprices integration execution risk at KMB (market treats synergies as done) while underestimating CVX’s buyback optionality if oil structurally tightens — both create asymmetric trades. The market may be overpaying for cyclically exposed independents; historical parallel: 2016 majors preserved dividends and regained market share — repeatable if managements remain disciplined. Unintended consequence: political/regulatory pressure could target large energy dividends if oil spikes and fuel inflation reaccelerates, creating idiosyncratic risk.